| Literature DB >> 23574918 |
Xavier Bonfill1, Marta Roqué, Marta Beatriz Aller, Dimelza Osorio, Carles Foradada, Angels Vives, David Rigau.
Abstract
BACKGROUND: The objective of this research is to generate quality of care indicators from systematic reviews to assess the appropriateness of obstetric care in hospitals.Entities:
Mesh:
Year: 2013 PMID: 23574918 PMCID: PMC3626798 DOI: 10.1186/1748-5908-8-42
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
First phase: generation of clinical recommendations from systematic reviews
| Design and execution of a specific search strategy for identifying systematic reviews (SR). | |
| SR were included based on: | |
| An assessment of the methodological quality of each SR; we excluded those documents that did not meet one or more internal validity criteria of SIGN*. | |
| Generation of a clinical recommendation (for or against a particular intervention) from each SR. Definitions were provided for population, intervention, comparison and outcomes of interest. | |
| Assessment of the quality of evidence and strength of recommendation based on the GRADE† system. Only those recommendations that were considered strong and supported by high quality evidence remained selected. |
*SIGN: Scottish Intercollegiate Guidelines Network; †GRADE: Grading of Recommendations Assessment, Development and Evaluation.
General structure of an indicator
| a. Title | Brief statement of what is to be assessed | Research team |
| b. Type of Indicator | • Process indicator | Clinical recommendation based on SR |
| • Specific indicator of general or medical condition | ||
| • Indicator of desirable or undesirable events | ||
| • Indicator based on proportions or means | ||
| c. Definitions | 1. Clinical recommendation (PICO format): Clinical situation, population, intervention, comparison and main outcomes | Clinical recommendation based on SR, ICD-9-CM |
| • Operational definition of clinical terms in the research question | ||
| • Definition of contraindications to treatment (if necessary) | ||
| • Description of the diagnostic and procedure codes ICD-9-CM for the identification of the population | ||
| d. Target population | Definition of the target population | Clinical recommendation based on SR |
| e. Rationale | • Impact of the clinical condition of interest | SR, CPG |
| • Brief description of the selected SR | ||
| • Summary of the main benefits and/or harms associated with the intervention | ||
| • Support of the recommendation by main clinical practice guidelines (CPG) | ||
| f. Supporting literature | Main bibliography that supports the indicator (SR and CPG) | SR, CPG |
| g. Description of indicator population | Operational definition of the indicator (formula) | Clinical recommendation based on SR, clinical experts |
| • Numerator / denominator | ||
| • Exclusion criteria | ||
| h. Sources of information | Description of the sources of information to compute the indicator: | Clinical experts |
| • Administrative databases (mainly from inpatient and surgical area) | ||
| • Clinical documentation (medical history) | ||
| • Other (survey, etc.) | ||
| i. Standard | Definition of the standard: | Clinical recommendation based on SR |
| • Desirable event (↑) | ||
| • Undesirable event (↓) | ||
| j. Underlying factors | • Factors related to the target population | SR, CPG, Clinical experts |
| • Factors related to professionals | ||
| • Factors related to the hospital | ||
| k. Notes | Other aspects that complement the information summarized by the indicator. | Clinical experts |
| l. Desired characteristics of a hospital to ensure the viability of the indicator | • Essential features (associated with the identification of the denominator and the numerator) | Clinical experts |
| • Desirable features (associated with an acceptable time investment to measure it) |
Figure 1Short title: Study’s flowchart. Detailed legend: Flowchart of studies identified in the bibliographic search.
Quality of care indicators generated in the project
| 1 | Proportion of women with singleton pregnancies and threatened preterm labour (TPL) who receive corticosteroids25 | Women with TPL and preterm labour | 644.03, 644.10, 644.13, 644.20, 644.21 | D: Singleton pregnancies between 26-34w | ≈100 |
| N: Women who received corticoids | |||||
| E: Corticoids contraindications | |||||
| 2 | Proportion of women who are treated with calcium channel blockers (CCB) for inhibiting preterm labour26 | Women with TPL and preterm labour | 644.03, 644.10, 644.13, 644.20, 644.21 | D: Pregnancies between 22-34w | ≈100 |
| N: Women who received CCB | |||||
| E: Contraindication to CCB | |||||
| 3 | Proportion of women with threatened preterm labour treated with magnesium sulphate27 | Women with TPL and preterm labour | 644.03, 644.10, 644.13, 644.20, 644.21 | D: Women who received pharmacological treatment for TPL | ≈0 |
| N: Women who received magnesium sulphate | |||||
| E: None | |||||
| 4 | Proportion of women with preterm rupture of membranes (PRM) who receive antibiotic treatment28 | Women with PRM | 658.10, 658.11 | D: Pregnancies between 22-34w with PRM | ≈100 |
| N: Women who received antibiotics | |||||
| E: None | |||||
| 5 | Proportion of women with post-term pregnancy who give birth after 41 weeks of gestation29 | Women with >=41w pregnancy | 641.X1, 642.X1, 676.X1 | D: Women with > =41w pregnancy | ≈0 |
| N: Women with labour induction | |||||
| E: Spontaneous labour, non-urgent caesarean delivery | |||||
| 6 | Proportion of women with severe pre-eclampsia who were treated with magnesium sulphate30 | Women with severe preeclampsia | 642.5 | D: Women with severe pre-eclampsia | ≈100 |
| N: Women who received magnesium sulphate | |||||
| E: Contraindication to magnesium sulphate | |||||
| 7 | Proportion of women with eclampsia treated with magnesium sulphate22,23,24 | Women with eclampsia | 642.6 | D: Women with eclampsia | ≈100 |
| N: Women who received magnesium sulphate | |||||
| E: Contraindication to magnesium sulphate | |||||
| 8 | Proportion of women with term pregnancies and a breech presentation in which external cephalic version is performed or offered31 | Women with breech presentation | 73.91 | D: Breech presentation | ≈100 |
| N: Women in whom cephalic version was performed or offered | |||||
| E: None | |||||
| 9 | Proportion of unjustified episiotomies34 | Women in whom episiotomy was performed | 73.6 | D: Women in who episiotomy was performed | ≈0 |
| N: Procedures without any reason documented | |||||
| E: None | |||||
| 10 | Proportion of women whose second-degree perineal tear or episiotomy is repaired with continuous suture35 | Women with second-degree perineal tear or episiotomy | 664.10, 664.11, 644.14, 73.6 | D: Women with second-degree perineal tear or episiotomy | ≈100 |
| N: Women in whom continuous suture was performed | |||||
| E: None | |||||
| 11 | Proportion of women who are given an enema during labour36 | Women in labour | 641.X1, 642.X1, 676.X1 | D: Women in labour | ≈0 |
| N: Women who were given an enema | |||||
| E: None | |||||
| 12 | Proportion of women having perineal shaving on admission to the delivery room37 | Women in labour | 641.X1, 642.X1, 676.X1 | D: Women in labour | ≈0 |
| N: Women for whom perineal shaving was performed | |||||
| E: None | |||||
| 13 | Proportion of women who are administered uterotonics in the third stage of labour38 | Women in labour | 641.X1, 642.X1, 676.X1 | D: Women in labour | ≈100 |
| N: Women who received uterotonics | |||||
| E: Contraindication to uterotonics, patient refusal to receive uterotonics | |||||
| 14 | Proportion of women undergoing caesarean section who receive antibiotic therapy39 | Women on whom caesarean was performed | 74.XX | D: Women who received caesarean | ≈100 |
| N: Women who received antibiotics | |||||
| E: None | |||||
| 15 | Proportion of women whose peritoneum is sutured at caesarean delivery40 | Women on whom caesarean was performed | 74.XX | D: Women who received caesarean | ≈0 |
| N: Women for who peritoneum was sutured | |||||
| E: None | |||||
| 16 | Proportion of health professionals who use double gloves when attending a woman with a blood-borne disease43 | Health professionals performing surgical procedures | None | D: Health professionals who performed surgical procedures in woman with a blood-borne disease | ≈100 |
| N: Health professionals who used double gloves | |||||
| E: None | |||||
| 17 | Proportion of Rh-negative women who are given Anti-D within 72 hours after the birth of an Rh-positive or Rh-undetermined baby41 | Rh-negative pregnant women | None | D: Rh-negative women with Rh-positive newborn | ≈100 |
| N: Women who received Anti-D | |||||
| E: Women with prior Rh sensitization. | |||||
| 18 | Proportion of women with incomplete miscarriage who, if a surgical evacuation of retained products is carried out, undergo a vacuum aspiration42 | Women with incomplete miscarriage | 634.X1 -638.X1 | D: Women with incomplete miscarriage | ≈100 |
| | | | | N: Women in who vacuum aspiration was performed | |
| E: Contraindication to vacuum aspiration |
a In this column, the value “X” means any number between 0 to 9.
b In this column, (D) Denominator, (N) Numerator (E) Exclusion criteria.
c Theoretical standards: 100% means a desirable event (higher values indicate appropriate performance) and 0% an undesirable event (lower values indicate inappropriate performance).